1. Home
  2. LPCN vs GWH Comparison

LPCN vs GWH Comparison

Compare LPCN & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • GWH
  • Stock Information
  • Founded
  • LPCN 1997
  • GWH 2011
  • Country
  • LPCN United States
  • GWH United States
  • Employees
  • LPCN N/A
  • GWH N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • LPCN Health Care
  • GWH Miscellaneous
  • Exchange
  • LPCN Nasdaq
  • GWH Nasdaq
  • Market Cap
  • LPCN 16.1M
  • GWH 17.1M
  • IPO Year
  • LPCN N/A
  • GWH N/A
  • Fundamental
  • Price
  • LPCN $3.29
  • GWH $1.20
  • Analyst Decision
  • LPCN Strong Buy
  • GWH Hold
  • Analyst Count
  • LPCN 2
  • GWH 5
  • Target Price
  • LPCN $9.00
  • GWH $2.10
  • AVG Volume (30 Days)
  • LPCN 59.4K
  • GWH 2.2M
  • Earning Date
  • LPCN 08-07-2025
  • GWH 08-13-2025
  • Dividend Yield
  • LPCN N/A
  • GWH N/A
  • EPS Growth
  • LPCN N/A
  • GWH N/A
  • EPS
  • LPCN N/A
  • GWH N/A
  • Revenue
  • LPCN $3,674,834.00
  • GWH $4,155,999.00
  • Revenue This Year
  • LPCN N/A
  • GWH $179.38
  • Revenue Next Year
  • LPCN N/A
  • GWH $175.77
  • P/E Ratio
  • LPCN N/A
  • GWH N/A
  • Revenue Growth
  • LPCN N/A
  • GWH N/A
  • 52 Week Low
  • LPCN $2.68
  • GWH $0.76
  • 52 Week High
  • LPCN $8.71
  • GWH $14.10
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 51.52
  • GWH 44.07
  • Support Level
  • LPCN $3.13
  • GWH $0.95
  • Resistance Level
  • LPCN $3.53
  • GWH $1.44
  • Average True Range (ATR)
  • LPCN 0.24
  • GWH 0.12
  • MACD
  • LPCN 0.01
  • GWH 0.05
  • Stochastic Oscillator
  • LPCN 48.33
  • GWH 50.00

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: